ATE346611T1 - Verbesserte dns impfstoffe für rinder-herpes virus 1 - Google Patents

Verbesserte dns impfstoffe für rinder-herpes virus 1

Info

Publication number
ATE346611T1
ATE346611T1 AT01907651T AT01907651T ATE346611T1 AT E346611 T1 ATE346611 T1 AT E346611T1 AT 01907651 T AT01907651 T AT 01907651T AT 01907651 T AT01907651 T AT 01907651T AT E346611 T1 ATE346611 T1 AT E346611T1
Authority
AT
Austria
Prior art keywords
herpes virus
dna vaccines
improved dna
bovine herpes
bovine
Prior art date
Application number
AT01907651T
Other languages
English (en)
Inventor
Jean-Christophe Franc Audonnet
Laurent Bernard Fischer
Simona Barzu-Le-Roux
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE346611T1 publication Critical patent/ATE346611T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT01907651T 2000-01-21 2001-01-19 Verbesserte dns impfstoffe für rinder-herpes virus 1 ATE346611T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000798A FR2804028B1 (fr) 2000-01-21 2000-01-21 Vaccins adn ameliores pour animaux de rente

Publications (1)

Publication Number Publication Date
ATE346611T1 true ATE346611T1 (de) 2006-12-15

Family

ID=8846183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01907651T ATE346611T1 (de) 2000-01-21 2001-01-19 Verbesserte dns impfstoffe für rinder-herpes virus 1

Country Status (21)

Country Link
EP (1) EP1248650B1 (de)
JP (1) JP2004500375A (de)
KR (1) KR100820893B1 (de)
CN (2) CN101554480A (de)
AR (1) AR027926A1 (de)
AT (1) ATE346611T1 (de)
AU (1) AU783865B2 (de)
BR (2) BR0107767A (de)
CA (1) CA2398229C (de)
CY (1) CY1107627T1 (de)
DE (1) DE60124862T2 (de)
DK (1) DK1248650T3 (de)
ES (1) ES2277913T3 (de)
FR (1) FR2804028B1 (de)
HU (1) HU229597B1 (de)
MX (1) MXPA02007110A (de)
NZ (1) NZ520270A (de)
PL (1) PL209304B1 (de)
PT (1) PT1248650E (de)
WO (1) WO2001052888A2 (de)
ZA (1) ZA200205698B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
AU2003301148A1 (en) 2002-12-23 2004-07-22 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
WO2004073737A1 (en) * 2003-02-19 2004-09-02 Merial Limited Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
CU23544A1 (es) 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
CA2797937C (en) * 2009-05-22 2020-01-14 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
KR20130118890A (ko) * 2010-11-19 2013-10-30 베이징 카윈 테크놀로지 쉐어-홀딩 컴퍼니 리미티드 B형 간염의 예방 및 치료를 위한 dna 백신 조성물
CN112034169A (zh) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679356A (en) * 1992-07-08 1997-10-21 Schering Corporation Use of GM-CSF as a vaccine adjuvant
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
JPH10508743A (ja) * 1994-09-09 1998-09-02 ニューロクライン バイオサイエンシーズ， インコーポレイテッド インターロイキン−１ タイプ３レセプター
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
CA2214029A1 (en) * 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
EP0833613A1 (de) * 1995-05-26 1998-04-08 Somatix Therapy Corporation Verabreichungsträger mit stabilen lipid/nuleinsäure komplexen
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
AU1987197A (en) * 1997-03-10 1998-09-29 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purpose
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
AU782154C (en) * 1999-06-10 2006-02-09 Boehringer Ingelheim Animal Health USA Inc. DNA vaccines for pets and sport animals

Also Published As

Publication number Publication date
DK1248650T3 (da) 2007-04-16
CN101554480A (zh) 2009-10-14
HU229597B1 (en) 2014-02-28
CA2398229A1 (en) 2001-07-26
PL209304B1 (pl) 2011-08-31
CN1404398A (zh) 2003-03-19
PT1248650E (pt) 2007-02-28
AU783865B2 (en) 2005-12-15
BR0107767A (pt) 2002-11-12
KR20020084093A (ko) 2002-11-04
BRPI0107767B1 (pt) 2017-10-24
WO2001052888A2 (fr) 2001-07-26
EP1248650B1 (de) 2006-11-29
ZA200205698B (en) 2003-09-29
MXPA02007110A (es) 2003-01-28
KR100820893B1 (ko) 2008-04-10
CA2398229C (en) 2012-05-15
DE60124862D1 (de) 2007-01-11
DE60124862T2 (de) 2007-07-05
JP2004500375A (ja) 2004-01-08
HUP0203974A3 (en) 2004-07-28
AU3556601A (en) 2001-07-31
FR2804028A1 (fr) 2001-07-27
HUP0203974A2 (hu) 2003-03-28
ES2277913T3 (es) 2007-08-01
NZ520270A (en) 2004-08-27
PL356554A1 (en) 2004-06-28
WO2001052888A3 (fr) 2001-12-20
CN1404398B (zh) 2012-05-02
EP1248650A2 (de) 2002-10-16
FR2804028B1 (fr) 2004-06-04
AR027926A1 (es) 2003-04-16
CY1107627T1 (el) 2013-04-18

Similar Documents

Publication Publication Date Title
EE200200158A (et) Immunostimulatoorsed nukleiinhapped
NO20004758D0 (no) Vaksinesammensetning
ATE490327T1 (de) Impfstoffzusammensetzung
NO20014322L (no) Vaksine
GB2337755B (en) Virus vaccine
DK0870508T3 (da) Influenzavaccine
EP1083926A4 (de) Impfstoff
DE60114935T2 (de) Individuell anpassbare universal-daumenverbandsschiene
DK1192125T3 (da) Mono-substituerede 3-propyl-gamma-aminosmörsyrer
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763L (no) Vaksine
FR2776928B1 (fr) Vaccins adn adjuves
ATE346611T1 (de) Verbesserte dns impfstoffe für rinder-herpes virus 1
ATE367369T1 (de) Silikatmasse
NO20005599D0 (no) Vaksine
PT1137632E (pt) Tioureias inibidoras de virus herpes
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
DE69820434D1 (de) Eingebetteter luftentferner
IS2797B (is) Bóluefni gegn ISA-veiru
ITMI981384A1 (it) Vaccino per hiv
IT1317533B1 (it) Trasportatore aereo per segnature
GB9826647D0 (en) DNA vaccines
NO20002213D0 (no) Babesia vaksine
WO2002008390A3 (en) Bovine wasting syndrome vaccine
KR970051069U (ko) 대기 오염 제거 장치

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1248650

Country of ref document: EP